ID
42996
Description
Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609
Link
http://clinicaltrials.gov/ct2/show/record/NCT00661609
Keywords
Versions (3)
- 11/18/11 11/18/11 -
- 3/26/14 3/26/14 - Martin Dugas
- 9/17/21 9/17/21 -
Uploaded on
September 17, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility DRKS00004052 NCT00661609 Bladder Cancer
Eligibility Advanced Bladder Cancer NCT00661609
- StudyEvent: Eligibility
Description
Exclusion criteria
Alias
- UMLS CUI-1
- C0680251
Description
Prior treatment
Data type
boolean
Alias
- UMLS CUI-1
- C1514463
Description
Inadequate bone marrow reserve
Data type
boolean
Alias
- UMLS CUI-1
- CL406855
Description
Liver Dysfunction
Data type
boolean
Alias
- UMLS CUI-1
- C0086565
Description
Impaired renal function
Data type
boolean
Alias
- UMLS CUI-1
- C1565489
Similar models
Eligibility Advanced Bladder Cancer NCT00661609
- StudyEvent: Eligibility